Last update Jan. 25, 2022

Butriptyline Hydrochloride

Limited compatibility

Unsafe. Moderate/severe adverse effects. Compatible under certain circumstances. Follow-up recommended. Use safer alternative or discontinue breastfeeding from 5 to 7 T ½ . Read Commentary.

Tricyclic antidepressant derivative of amitriptyline with actions and uses similar to those of amitriptyline. It has marked antimuscarinic and sedative properties. Used in the treatment of depression.

Product with very few bibliographical references and that has been withdrawn from the market worldwide.

Alternatives

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Butriptyline Hydrochloride in other languages or writings:

Group

Butriptyline Hydrochloride belongs to this group or family:

Tradenames

Main tradenames from several countries containing Butriptyline Hydrochloride in its composition:

Pharmacokinetics

Variable Value Unit
Molecular weight 330 daltons
Protein Binding 90 %
Tmax 2.6 - 7.5 hours
20 hours

References

  1. Remakus BL, Kessel LJ, Trichtinger MD, Montgomery P, Griffiths JP. Butriptyline (Evadyne) and the Mexican connection. N Engl J Med. 1981 Jun 18;304(25):1543-4. No abstract available. Abstract
  2. Bourgouin J, Gagnon MA, Elie R, Dvornik D, Gonzalez R, Kraml M. Butriptyline: human pharmacokinetics and comparative bioavailability of conventional and sustained release formulations. Biopharm Drug Dispos. 1981 Apr-Jun;2(2):123-30. Abstract

Total visits

4,132

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM